Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

SLS Insider Trading

SELLAS Life Sciences Group, Inc. | Pharmaceutical Preparations

Comprehensive Trading Performance Summary

The investment history of corporate insiders at SELLAS Life Sciences Group, Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Pharmaceutical Preparations sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2025-11-21 16:45 2025-11-19 Kalin Katherine Bach Director BUY $1.59 63,400 $100,806 104,400 +154.6%
2025-06-13 15:00 2025-06-12 VAN NOSTRAND ROBERT L Director BUY $1.48 10,000 $14,800 20,400 +96.2%
2025-06-02 23:42 2025-05-30 Wasman Jane Director BUY $1.69 20,000 $33,800 30,400 +192.3%
2025-05-22 23:05 2025-05-22 Kalin Katherine Bach Director BUY $1.80 20,000 $36,000 41,000 +95.2%
2022-12-06 00:14 2022-12-05 Stergiou Angelos M. Director, Officer - President and CEO SELL $2.61 6,494 $16,938 161,689 -3.9%
2022-12-06 00:13 2022-12-05 Burns John Thomas Officer - Senior VP, Finance & CAO SELL $2.59 1,159 $3,002 29,347 -3.8%
2022-12-06 00:12 2022-12-05 WOOD BARBARA A Officer - EVP, Gen. Counsel, Corp. Sec. SELL $2.59 2,153 $5,576 56,344 -3.7%
2021-12-04 01:15 2021-12-02 Stergiou Angelos M. Director, Officer - President and CEO SELL $6.25 2,120 $13,252 121,167 -1.7%
2021-12-04 01:13 2021-12-02 Burns John Thomas Officer - VP, Finance & Corp Controller SELL $6.27 231 $1,448 17,644 -1.3%
2021-12-04 01:14 2021-12-02 WOOD BARBARA A Officer - EVP, Gen. Counsel, Corp. Sec. SELL $6.25 847 $5,298 42,028 -2.0%
2019-01-04 05:03 2018-12-31 Stergiou Angelos M. Director, Officer - President and CEO SELL $1.25 23,277 $29,189 426,858 -5.2%
2009-07-07 23:11 2009-07-07 LEWIS STEPHEN R JR Director BUY $5.58 1,000 $5,580 1,100 +1,000.0%
2009-02-18 03:28 2009-02-13 Kraska Stanley J Jr Other BUY $4.81 2,000 $9,615 7,000 +40.0%
2008-10-27 18:48 2008-10-24 Kraska Stanley J Jr Other BUY $6.24 1,000 $6,235 5,000 +25.0%
2008-10-03 01:49 2008-10-02 Kraska Stanley J Jr Other BUY $9.43 1,000 $9,425 4,000 +33.3%
2007-10-01 20:59 2007-09-28 GALVIN JOHN R Director BUY $18.74 538 $10,082 538 +100.0%
2007-09-27 22:55 2007-09-27 SHAFER ROBERT L Director BUY $18.23 1,000 $18,225 1,000 +100.0%
2007-09-27 22:46 2007-09-27 RICHIE LEROY C Director BUY $18.26 500 $9,130 500 +100.0%
2007-09-26 22:04 2007-09-26 Maher John F Director BUY $18.09 1,000 $18,090 1,000 +100.0%
2007-09-26 16:43 2007-09-24 MORRIS WILLIAM C Director, Other BUY $18.30 18,700 $342,210 31,300 +148.4%
2007-09-24 18:51 2007-09-21 MCPHERSON FRANK A Director BUY $18.64 500 $9,320 500 +100.0%
2007-09-24 22:41 2007-09-21 MORRIS WILLIAM C Director, Other BUY $18.30 8,600 $157,347 12,600 +215.0%
2007-08-30 17:58 2007-08-29 WHITSON JAMES N Director BUY $18.61 500 $9,307 500 +100.0%
2007-08-20 22:44 2007-08-16 Pauley Keith R Other BUY $16.37 3,075 $50,330 3,075 +100.0%
2007-08-17 23:52 2007-08-16 Kraska Stanley J Jr Other BUY $16.80 3,000 $50,395 3,000 +100.0%
2007-08-16 23:53 2007-08-16 ZINO BRIAN T Director, Officer - President and CEO BUY $16.70 1,000 $16,700 1,000 +100.0%
2007-07-24 21:44 2007-07-20 MICHEL BETSY Director BUY $23.41 1,000 $23,410 1,000 +100.0%
2007-06-07 00:16 2007-06-05 MORRIS WILLIAM C Director, Other BUY $25.10 4,000 $100,400 4,000 +100.0%
2006-04-08 00:31 2006-04-04 Lamar Steven Officer - President SELL $1.00 9,300 $9,300 0 -100.0%
2005-11-16 18:48 2005-11-04 MCKENNA MICHAEL J Director SELL $4.55 100 $455 29,600 -0.3%
2005-10-31 18:52 2005-10-27 GORDER MARK STEPHEN Director, Officer, 10% owner - Chief Executive Officer BUY $4.11 10,000 $41,127 322,850 +3.2%
2005-10-31 21:50 2005-10-27 Gonsior Dennis Officer - Vice Pres., Global Operations BUY $3.80 1,000 $3,800 1,000 +100.0%
2005-10-31 18:19 2005-10-27 MCKENNA MICHAEL J Director BUY $3.95 500 $1,975 29,700 +1.7%
2005-11-01 04:09 2005-10-27 MASUCCI ROBERT N Director BUY $4.31 25,000 $107,690 48,200 +107.8%
2005-10-31 18:29 2005-10-28 GIORDANO NICHOLAS A Director BUY $4.27 1,000 $4,270 25,200 +4.1%
2005-11-01 00:50 2005-10-31 KULLBACK WILLIAM J Officer - Chief Financial Officer BUY $4.33 5,000 $21,630 5,000 +100.0%
2004-12-13 19:21 2004-12-10 GORDER MARK STEPHEN Director, Officer - President and CEO BUY $2.03 12,000 $24,404 312,850 +4.0%
2004-09-29 21:07 2004-09-27 GORDER MARK STEPHEN Director, Officer - President and CEO BUY $1.97 1,000 $1,970 300,850 +0.3%
2004-08-19 15:46 2004-08-18 GORDER MARK STEPHEN Director, Officer - President and CEO BUY $1.64 5,000 $8,200 299,850 +1.7%
2004-08-19 21:45 2004-08-19 GALLAGHER ROBERT F Officer - CFO, Treasurer & Secretary BUY $1.87 10,000 $18,700 33,200 +43.1%
2004-06-25 19:24 2004-06-23 GORDER MARK STEPHEN Director, Officer - President and CEO BUY $3.08 1,000 $3,075 294,850 +0.3%
2004-06-18 00:23 2004-06-16 GORDER MARK STEPHEN Director, Officer - President and CEO BUY $3.27 1,000 $3,265 293,850 +0.3%
2004-06-14 15:03 2004-06-09 GORDER MARK STEPHEN Director, Officer - President and CEO BUY $3.25 1,000 $3,250 292,850 +0.3%
2004-06-08 18:48 2004-06-02 GORDER MARK STEPHEN Director, Officer - President and CEO BUY $3.13 1,000 $3,130 291,850 +0.3%
2004-06-02 18:48 2004-05-19 GORDER MARK STEPHEN Director, Officer - President and CEO BUY $2.92 2,000 $5,840 290,850 +0.7%
2004-04-12 18:18 2004-04-06 GORDER MARK STEPHEN Director, Officer - President and CEO BUY $2.38 1,000 $2,380 288,850 +0.3%
2003-11-18 23:51 2003-11-14 GORDER MARK STEPHEN Director, Officer - President & CEO BUY $1.75 23,200 $40,600 287,850 +8.8%
2003-11-18 23:52 2003-11-14 MCKENNA MICHAEL J Director BUY $1.75 23,200 $40,600 23,200 +100.0%
2003-11-18 23:53 2003-11-14 MASUCCI ROBERT N Director BUY $1.75 23,200 $40,600 23,200 +100.0%
2003-11-18 23:50 2003-11-14 GIORDANO NICHOLAS A Director BUY $1.75 23,200 $40,600 23,200 +100.0%
SHOW ENTRIES

How to Interpret $SLS Trades

Not every insider transaction in SELLAS Life Sciences Group, Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $SLS shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for SLS

Insider activity data for SELLAS Life Sciences Group, Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $SLS, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.